Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled MSC-Derived Exosomes for Post-Infectious Cough
NCT07103980Phase 2Recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Jul 2024
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postinfectious cough (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoint: Change in Leicester Cough Questionnaire at Day 7. Started Jul 2024; status: recruiting.
02
Conditions
postinfectious cough
Beyond the preview
Go deeper on NCT07103980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07103980.